PRRC2A and type 2 diabetes mellitus: Overall, our integrative genomic and adipocyte functional studies are consistent with lower methylation levels at cg15809217 in obese subcutaneous adipocytes promoting insulin resistance and T2D, through reduced PRRC2A expression and impaired adipogenesis.